Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials (Q45256460)

From Wikidata
Jump to navigation Jump to search
scientific article published on 23 September 2011
edit
Language Label Description Also known as
English
Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials
scientific article published on 23 September 2011

    Statements

    Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials (English)
    Matthew Siegel
    Mitchell E Garber
    Andrew G Spencer
    Wendy Botwick
    Pawan Kumar
    Robert N Williams
    Kenji Kozuka
    Revati Shreeniwas
    Vijaya Pratha
    Daniel C Adelman
    23 September 2011
    440-450

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit